SEC Company Response from Black Bird Biotech, Inc. (BBBT) (CIK 0001409999) — Feb 15, 2023

Black Bird Biotech, Inc. (BBBT) (CIK 0001409999)
Date: Feb. 15, 2023 · CIK: 0001409999 · Accession: 0001477932-23-001076

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-269630

Date

February 15, 2023

Author

/s/ Fabian G. Deneault

Form

CORRESP

Company

Black Bird Biotech, Inc. (BBBT) (CIK 0001409999)

Letter

bbbt_corresp.htmBLACK BIRD BIOTECH, INC.

11961 Hilltop Road, Suite 22

Argyle, Texas 76226

February 15, 2023

Office of Manufacturing

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Attention: Gregory Herbers

Re:

Black Bird Biotech, Inc.

Registration Statement on Form S-1

File No. 333-269630

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Black Bird Biotech, Inc. (the “Company”) respectfully requests that the Securities and Exchange Commission take such action as may be necessary and proper in order that the Registration Statement on Form S-1 (Registration No. 333-269630) (the “Registration Statement”), be declared effective at 9:00 a.m. (Washington, D.C. time), on February 17, 2023, or as soon thereafter as practicable.

Please call Eric Newlan at (940) 367-6154 to provide notice of the effectiveness of the Registration Statement.

Respectfully submitted,
/s/ Fabian G. Deneault

Show Raw Text

CORRESP
1
filename1.htm

bbbt_corresp.htmBLACK BIRD BIOTECH, INC.

 11961 Hilltop Road, Suite 22

 Argyle, Texas 76226

 February 15, 2023

 Office of Manufacturing

 Division of Corporation Finance

 U.S. Securities and Exchange Commission

 100 F Street, NE

 Washington, DC 20549

 Attention: Gregory Herbers

   Re:

   Black Bird Biotech, Inc.

 Registration Statement on Form S-1

 File No. 333-269630

 Ladies and Gentlemen:

 Pursuant to Rule 461 under the Securities Act of 1933, as amended, Black Bird Biotech, Inc. (the “Company”) respectfully requests that the Securities and Exchange Commission take such action as may be necessary and proper in order that the Registration Statement on Form S-1 (Registration No. 333-269630) (the “Registration Statement”), be declared effective at 9:00 a.m. (Washington, D.C. time), on February 17, 2023, or as soon thereafter as practicable.

 Please call Eric Newlan at (940) 367-6154 to provide notice of the effectiveness of the Registration Statement.

       Respectfully submitted,

    /s/ Fabian G. Deneault

     Fabian G. Deneault

     President

SecProbe.io